BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37330521)

  • 1. The association and prediction value of acylcarnitine on diabetic nephropathy in Chinese patients with type 2 diabetes mellitus.
    Li X; Miao Y; Fang Z; Zhang Q
    Diabetol Metab Syndr; 2023 Jun; 15(1):130. PubMed ID: 37330521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association Between Acylcarnitine Metabolites and Cardiovascular Disease in Chinese Patients With Type 2 Diabetes Mellitus.
    Zhao S; Feng XF; Huang T; Luo HH; Chen JX; Zeng J; Gu M; Li J; Sun XY; Sun D; Yang X; Fang ZZ; Cao YF
    Front Endocrinol (Lausanne); 2020; 11():212. PubMed ID: 32431666
    [No Abstract]   [Full Text] [Related]  

  • 3. Medium & long-chain acylcarnitine's relation to lipid metabolism as potential predictors for diabetic cardiomyopathy: a metabolomic study.
    Zheng DM; An ZN; Ge MH; Wei DZ; Jiang DW; Xing XJ; Shen XL; Liu C
    Lipids Health Dis; 2021 Nov; 20(1):151. PubMed ID: 34727932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between Acylcarnitine and Peripheral Neuropathy in Type 2 Diabetes Mellitus.
    An Z; Zheng D; Wei D; Jiang D; Xing X; Liu C
    J Diabetes Res; 2022; 2022():8115173. PubMed ID: 35224109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of free carnitine and acylcarnitines in plasma by HILIC-ESI-MS/MS without derivatization.
    Peng M; Liu L; Jiang M; Liang C; Zhao X; Cai Y; Sheng H; Ou Z; Luo H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():12-8. PubMed ID: 23816563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between Acylcarnitine and the Risk of Retinopathy in Type 2 Diabetes Mellitus.
    Wang WY; Liu X; Gao XQ; Li X; Fang ZZ
    Front Endocrinol (Lausanne); 2022; 13():834205. PubMed ID: 35370967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short and medium chain acylcarnitines as markers of outcome in diabetic and non-diabetic subjects with acute coronary syndromes.
    Davies A; Wenzl FA; Li XS; Winzap P; Obeid S; Klingenberg R; Mach F; Räber L; Muller O; Matter CM; Laaksonen R; Wang Z; Hazen SL; Lüscher TF
    Int J Cardiol; 2023 Oct; 389():131261. PubMed ID: 37574027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnitine acetyltransferase: A new player in skeletal muscle insulin resistance?
    Berg SM; Beck-Nielsen H; Færgeman NJ; Gaster M
    Biochem Biophys Rep; 2017 Mar; 9():47-50. PubMed ID: 28955988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Acylcarnitines and Risk of Type 2 Diabetes in a Mediterranean Population at High Cardiovascular Risk.
    Guasch-Ferré M; Ruiz-Canela M; Li J; Zheng Y; Bulló M; Wang DD; Toledo E; Clish C; Corella D; Estruch R; Ros E; Fitó M; Arós F; Fiol M; Lapetra J; Serra-Majem L; Liang L; Papandreou C; Dennis C; Martínez-González MA; Hu FB; Salas-Salvadó J
    J Clin Endocrinol Metab; 2019 May; 104(5):1508-1519. PubMed ID: 30423132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry with derivatization method for concurrent measurement of amino acids and acylcarnitines in plasma of diabetic type 2 patients with diabetic nephropathy.
    Esmati P; Najjar N; Emamgholipour S; Hosseinkhani S; Arjmand B; Soleimani A; Kakaii A; Razi F
    J Diabetes Metab Disord; 2021 Jun; 20(1):591-599. PubMed ID: 34222079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similarities in serum acylcarnitine patterns in type 1 and type 2 diabetes mellitus and in metabolic syndrome.
    Bene J; Márton M; Mohás M; Bagosi Z; Bujtor Z; Oroszlán T; Gasztonyi B; Wittmann I; Melegh B
    Ann Nutr Metab; 2013; 62(1):80-5. PubMed ID: 23296094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acylcarnitine removal in a patient with acyl-CoA beta-oxidation deficiency disorder: effect of L-carnitine therapy and starvation.
    Fontaine M; Briand G; Vallée L; Ricart G; Degand P; Divry P; Vianey-Saban C; Vamecq J
    Clin Chim Acta; 1996 Aug; 252(2):109-22. PubMed ID: 8853559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma acylcarnitines inadequately reflect tissue acylcarnitine metabolism.
    Schooneman MG; Achterkamp N; Argmann CA; Soeters MR; Houten SM
    Biochim Biophys Acta; 2014 Jul; 1841(7):987-94. PubMed ID: 24747043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transorgan fluxes in a porcine model reveal a central role for liver in acylcarnitine metabolism.
    Schooneman MG; Ten Have GA; van Vlies N; Houten SM; Deutz NE; Soeters MR
    Am J Physiol Endocrinol Metab; 2015 Aug; 309(3):E256-64. PubMed ID: 26037250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of plasma free amino acids, carnitine and acylcarnitines, and JAK2
    Hassan MH; Galal O; Sakhr HM; Kamaleldeen EB; Zekry NF; Fateen E; Toghan R
    Biomed Chromatogr; 2023 Dec; 37(12):e5747. PubMed ID: 37728037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between acylcarnitine and amino acids profile and metabolic syndrome and its components in Iranian adults: Data from STEPs 2016.
    Taghizadeh H; Emamgholipour S; Hosseinkhani S; Arjmand B; Rezaei N; Dilmaghani-Marand A; Ghasemi E; Panahi N; Dehghanbanadaki H; Ghodssi-Ghassemabadi R; Najjar N; Asadi M; Khoshniat M; Larijani B; Razi F
    Front Endocrinol (Lausanne); 2023; 14():1058952. PubMed ID: 36923214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between plasma free amino acids and type 2 diabetes mellitus complicated with infection in Chinese patients.
    Zhang JX; Luo WM; Wang BW; Li RT; Zhang Q; Zhang XY; Fang ZZ; Zhang ZP
    Diabetol Metab Syndr; 2024 Jan; 16(1):9. PubMed ID: 38191455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine.
    Chalmers RA; Roe CR; Stacey TE; Hoppel CL
    Pediatr Res; 1984 Dec; 18(12):1325-8. PubMed ID: 6441143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human serum acylcarnitine profiles in different glucose tolerance states.
    Zhang X; Zhang C; Chen L; Han X; Ji L
    Diabetes Res Clin Pract; 2014 Jun; 104(3):376-82. PubMed ID: 24837145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and Validation of a Nomogram Model for Prediction of Diabetic Nephropathy in Type 2 Diabetic Patients with Proteinuria.
    Zhou DM; Wei J; Zhang TT; Shen FJ; Yang JK
    Diabetes Metab Syndr Obes; 2022; 15():1101-1110. PubMed ID: 35431563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.